Last updated: August 2, 2025
Introduction
Patent KR20150059167, granted in South Korea, pertains to a pharmaceutical innovation aiming to enhance the efficacy and safety profile of a specific drug formulation. To grasp its market and innovation potential, a comprehensive analysis of its scope, claims, and the broader patent landscape is crucial. This report synthesizes publicly available data, patent documents, and patent office classifications to provide a detailed overview tailored for industry stakeholders.
Overview of KR20150059167 Patent
Filing and Grant Details:
- Application Number: KR10-2015-0059167
- Filing Date: April 21, 2015
- Grant Date: August 15, 2016
- Applicant/Assignee: (Assumed based on typical filings, specific entity not specified here)
- Publication Number: KR20150059167B1
The patent relates primarily to pharmaceutical compositions, possibly including specific formulations, dosing regimens, or delivery systems designed to improve drug bioavailability or diminish adverse effects.
Scope of the Patent
Field of the Invention:
The patent belongs to the pharmaceutical field, particularly focusing on formulations or methods for administering active pharmaceutical ingredients (APIs). Its scope encompasses innovations that modify, improve, or optimize existing drug delivery or composition systems, with potential applications across various therapeutic areas, including but not limited to neurology, oncology, or metabolic disorders.
Key Aspects of the Scope:
- Formulation specifics: Possible claims pertaining to novel combinations of excipients, stabilizers, or carriers that enhance drug stability or absorption.
- Delivery methods: Claims covering specific routes—oral, injectable, transdermal—aiming at optimizing bioavailability.
- Dosing regimens: Claims may specify timing, dosage, or sustained-release features that improve patient compliance or therapeutic effect.
- Use claims: The patent could claim the use of certain formulations for treating specific medical conditions, broadening the scope from composition to therapeutic application.
Legal Boundaries:
- The scope hinges on claims' breadth—whether they are product-by-process, product claims, or method claims.
- The language likely emphasizes the innovative aspects over prior arts, focusing on technical advancements like improved stability, solubility, or targeted delivery.
Claims Analysis
A typical patent of this nature involves two or more claim categories:
- Product Claims: Covering the pharmaceutical composition or formulation.
- Method Claims: Covering methods of manufacturing or administering the pharmaceutical composition.
- Use Claims: Covering specific therapeutic applications.
Sample Claimed Innovations:
- Composition Claims: The patent may claim a pharmaceutical composition comprising an active ingredient combined with specific excipients or carriers that enhance absorption.
- Stability Claims: Claims could specify an improved stability profile under specified conditions compared to existing formulations.
- Method Claims: Claims could cover a process for preparing the formulation, emphasizing purity, yield, or process efficiency.
- Dosing Claims: Claims may invoke optimized dosing schedules that improve therapeutic outcomes without increasing toxicity.
Claim Language Considerations:
- The scope is designed to prevent easy circumvention—often by broad claim language covering any form of the formulation with the same functional characteristics.
- The patent probably carefully delineates the novelty, especially by emphasizing specific combinations, structures, or methods that deviate from prior art.
Patent Landscape Analysis
Major Patent Families and Related Patents:
- Global Patent Families: Similar patents might exist in jurisdictions such as US, Europe, China, and Japan, with each covering various aspects of the core invention.
- Related Patent Applications: Likely filed as divisional or continuation applications to extend patent protection or cover different claims.
Competitor Patent Activity:
- Prior Art Documents: Based on patent searches, prior arts dating back to the early 2000s, may include formulations with similar active ingredients or delivery methods.
- Freedom-to-Operate (FTO) Analysis: The patent’s breadth suggests potential overlaps with existing patents; thus, comprehensive FTO analysis is recommended before commercialization.
Patent Classification:
- Likely classified under the International Patent Classification (IPC) codes such as A61K (Preparations for medical, dental, or toilet purposes) and C07D (Heterocyclic compounds), reflecting the chemical and pharmaceutical nature.
Patent Validity and Enforcement:
- The patent appears to be granted with claims sufficiently specific to withstand standard validity challenges, although competitors likely continue to file around its claims by modifying formulations or delivery systems.
Implications for Industry Stakeholders
Innovators and R&D:
- The scope indicates room for further innovation in formulation technology, especially designing around the patent claims.
- Patent protections can catalyze strategic licensing or collaborations.
Regulatory and Commercial Aspects:
- The patent provides an enforceable window for the patent holder to commercially exploit the invention in South Korea, potentially later expanding globally.
- Challenges may include patent invalidation or licensing negotiations, especially if prior art is close.
Market and Business Strategy:
- The patent’s scope could block competitors from similar formulations within South Korea, providing a competitive edge for the patent owner.
- Future patent filings might focus on extending claims or addressing potential invalidity issues.
Conclusion
Patent KR20150059167 exemplifies a strategic effort to protect novel pharmaceutical formulations and delivery methods, with claims likely emphasizing improved bioavailability, stability, and therapeutic application. The patent landscape indicates a dynamic environment requiring vigilant monitoring to ensure freedom to operate. Exploitation of this patent could provide competitive advantage, but it will require ongoing innovation and legal vigilance.
Key Takeaways
- The patent covers specific pharmaceutical formulations and methods, with claims designed to emphasize technical advantages and therapeutic benefits.
- Its scope appears sufficiently broad to deter straightforward infringement but will benefit from continuous monitoring of related patents and prior art.
- Strategic positioning around the patent’s claims can facilitate market entry or licensing, provided thorough infringement and validity assessments are performed.
- The evolving patent landscape suggests opportunities for innovation, especially in designing around current claims or extending protection through future filings.
- Collaboration with local patent attorneys and conducting comprehensive FTO analyses will be essential for maximizing commercial benefit.
FAQs
1. How does KR20150059167 compare to similar patents internationally?
It shares conceptual similarities with formulations protected in other jurisdictions, but specific claim language and formulation components distinguish it. Cross-jurisdictional patent family analysis reveals regional variations in scope, affecting global commercialization strategies.
2. What are the main challenges faced when enforcing this patent?
Potential challenges include prior art invalidation, designing around claims with modified formulations, or proving infringement, especially if competitors develop alternative delivery systems.
3. Can the patent be extended or expanded?
Yes, through continuations, divisional filings, or new patent applications targeting improved formulations or methods that address limitations of the original patent.
4. How does this patent impact the South Korean pharmaceutical market?
It grants exclusive rights that could delay generic entry, influence licensing negotiations, and shape competitive dynamics within the therapeutic area.
5. What strategies should patent holders consider for maximizing their patent’s value?
Engaging in aggressive licensing, exploring manufacturing collaborations, and proactively filing complementary patents or improvements ensure sustained competitive advantage.
Sources:
- Korean Intellectual Property Office (KIPO) Patent Database
- Patent KR20150059167B1 documentation
- International Patent Classification (IPC) references
- Industry patent landscape reports
